Core Insights - The 2025 14th Annual Conference on the Development of Listed Companies and the Hainan Free Trade Port Opportunities Exchange Conference will be held in Haikou, Hainan from December 11 to 13, 2025, focusing on the development opportunities for listed companies [1] - Wu Wenjing, the Secretary of the Board of Jiangsu Huayang Intelligent Equipment Co., Ltd. (stock code: 301502), was awarded the title of "2025 Best Secretary of the Board of the Growth Enterprise Market," highlighting the company's governance level and development potential [1][3] Company Overview - Huayang Intelligent is committed to the core values of "Quality Achieves Development, Innovation Creates the Future" and aims for a strategic goal of "Centennial Huayang, 10 Billion Market Value," steadily progressing in the precision motor and medical device sectors [3] - The company has established three production bases and four wholly-owned subsidiaries, holding qualifications such as two national high-tech enterprises and one provincial enterprise technology center, which solidify its foundation for high-quality development [3] Business Performance - In the motor industry, Huayang Intelligent serves leading home appliance companies like Midea, Gree, Haier, Hisense, and Aux, becoming a core supplier due to its strong technology and product quality [4] - The medical device segment has successfully developed precision drug delivery devices such as electronic injection pens and micro-infusion pumps, which are used for various medications, and has established long-term partnerships with well-known pharmaceutical companies [4] - The company successfully went public on the Shenzhen Stock Exchange's Growth Enterprise Market on February 2, 2024, marking a new chapter in its capitalized development [4] Future Outlook - Wu Wenjing's recognition is seen as a milestone in her career and reflects Huayang Intelligent's emphasis on standardized operations and investor relations management [4] - The company plans to leverage this recognition to further develop micro-special motors and transmission technologies, expand into smart home and smart medical applications, and enhance innovation in drug delivery devices to deliver better performance for investors and society [4]

内容概要：微量注射泵作为现代医疗的关键设备，正以给药、智能控制为核心，推动着临床治疗的安全 性与效率升级。随着人口老龄化与慢性病管理需求激增，微量注射泵的市场规模持续扩张。数据显示， 2019年中国微量注射泵行业市场规模达到24.77亿元，到了2024年行业市场规模增长至33.56亿元，年复 合增长率为6.3%。预计未来随着医疗技术的不断进步以及对精准医疗需求的上升，微量注射泵的市场 渗透率持续提高，行业整体呈现出稳步增长的态势。 相关上市企业：迈瑞医疗（300760）、华阳智能（301502）、微创医疗（00853）、鱼跃医疗 （002223）、中红医疗（300981）等。 相关企业：深圳圣诺医疗设备股份有限公司、上海安洁电子设备有限公司、浙江史密斯医学仪器有限公 司、郑州瑞宇科技有限公司、大连万德电子有限公司、苏州泽德医疗器械有限公司、上海蓝德医疗器械 有限公司、广州欧浦瑞医疗科技有限公司、北京思路高高科技发展有限公司、深圳麦科田生物医疗技术 股份有限公司等。 关键词：微量注射泵行业相关政策、微量注射泵行业产业链、微量注射泵行业市场规模 一、微量注射泵行业相关概述 微量注射泵（简称微量泵）是一种新型泵力仪 ...